Mera Pharmaceuticals Inc
Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. The company is also involved in the development of sea salt; and operation of family entertainment center focused on promoting health and wellness through the Villari's system of martial arts. In addition, it provides foo… Read more
Market Cap & Net Worth: Mera Pharmaceuticals Inc (MRPI)
Mera Pharmaceuticals Inc (PINK:MRPI) has a market capitalization of $55.73K ($55.73K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51123 globally and #15827 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mera Pharmaceuticals Inc's stock price $0.00 by its total outstanding shares 557299676 (557.30 Million).
Mera Pharmaceuticals Inc Market Cap History: 2015 to 2025
Mera Pharmaceuticals Inc's market capitalization history from 2015 to 2025. Data shows change from $111.46K to $55.73K (-10.96% CAGR).
Mera Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Mera Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MRPI by Market Capitalization
Companies near Mera Pharmaceuticals Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Mera Pharmaceuticals Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Mera Pharmaceuticals Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Mera Pharmaceuticals Inc's market cap moved from $111.46K to $ 55.73K, with a yearly change of -10.96%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $55.73K | 0.00% |
| 2024 | $55.73K | 0.00% |
| 2023 | $55.73K | 0.00% |
| 2022 | $55.73K | -50.00% |
| 2021 | $111.46K | -95.83% |
| 2020 | $2.68 Million | +1100.00% |
| 2019 | $222.92K | 0.00% |
| 2018 | $222.92K | -50.00% |
| 2017 | $445.84K | -46.67% |
| 2016 | $835.95K | +650.00% |
| 2015 | $111.46K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Mera Pharmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $55.73K USD |
| MoneyControl | $55.73K USD |
| MarketWatch | $55.73K USD |
| marketcap.company | $55.73K USD |
| Reuters | $55.73K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.